Eplerenone

Basic Information


CAS ID: 107724-20-9
Molecular Formula: C24H30O6
Molecular Weight: 414.5 g/mol
Monoisotopic Mass: 414.2042 g/mol
Class: Small Molecule
Natural Product: No
Other Names: SC-6611O | INSPRA | SC-66110 | EPLERENONE
Analysis: Drug repositioning mechanism analysis

O O O O O O


Compound Structure and Identifier


InChI: InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1 See All
InChI Key: JUKPWJGBANNWMW-VWBFHTRKSA-N
Smiles: COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14 See All
Molfile: Download


Related Target


Target ID Name Interaction
T0536 Mineralocorticoid receptor antagonist

Related Fibrosis Property


Reference Record 1

PubMed ID 24083804 Target ID T0536
Uniprot ID Mineralocorticoid receptor Name Mineralocorticoid receptor
Model human Fibrosis Disease Cardiac fibrosis
Process I
Process II
Process III
Mechanism

Reference Record 2

PubMed ID 21734100 Target ID T0536
Uniprot ID Mineralocorticoid receptor Name Mineralocorticoid receptor
Model mice Fibrosis Disease Renal fibrosis
Process I attenue inflammation
Process II EMT,fibroblasts proliferation
Process III prevenet collagen deposition
Mechanism

Reference Record 3

PubMed ID 29216985 Target ID
Uniprot ID Name
Model sheep Fibrosis Disease Cardiac fibrosis
Process I
Process II myofibroblasts proliferation
Process III prevenet collagen deposition
Mechanism

Trial Record 1

ClinicalTrial ID NCT00401856 Disease Cardiac fibrosis
Phase Phase 4 Status Unknown
First Received November 22, 2006 Last Verified December 11, 2008
Sponsor Royal Brompton & Harefield NHS Foundation Trust

Trial Record 2

ClinicalTrial ID NCT01971593 Disease Cardiac fibrosis
Phase Phase 4 Status Terminated
First Received October 29, 2013 Last Verified May 4, 2018
Sponsor Washington University School of Medicine

Trial Record 3

ClinicalTrial ID NCT01801228 Disease Liver fibrosis
Phase Phase 2 Status Withdrawn
First Received February 28, 2013 Last Verified January 15, 2016
Sponsor Emma Nilsson

Trial Record 4

ClinicalTrial ID NCT02740179 Disease Cardiac fibrosis
Phase Not Applicable Status Recruiting
First Received April 15, 2016 Last Verified March 13, 2019
Sponsor Massachusetts General Hospital

Related Link


PubChem: 443872
ChEMBL: CHEMBL1095097